Evaluation of azithromycin in the treatment of pneumonia in ambulatory children: A randomized trial employing amoxicillin clavulanate or erythrotnycin estolate as comparative standard therapy

L. Wubbel, A. Ahmed, M. Trujillo, C. Mccoig, H. Jafri, K. Olsen, S. Shelton, L. Muniz, F. Brito, J. Hoyt, D. Bakken, C. Carubelli, T. Abramo, G. Mccracken

Research output: Contribution to journalArticle

Abstract

Community acquired pneumonia(CAP)in adults is commonly caused by viruses, bacteria, Mycoplasma pneumoniae(MP), and Chlamydia pneumoniae (CP), but there is less information about etiology in ambulatory children. In this single center ongoing prospective study we evaluated patients from 6 months to 16 yeans of age with radiographic and clinical evidence of pneumonia. Children were randomized 1:1 to receive azithromycin(azi)qd × 5days or augmentin(aug) and erythromycin(ery) TID x 10 days for those </=5 and >5 years, respectively. Patient samples were collected at diagnosis and again 2-3 weeks later. Between February 1996-Feb 1997, 111 patients were enrolled. There were 52% males and 64% were < 5 years. All blood cultures were sterile. Etiologic agents were identified by serology, NP/throat culture and PCR in 35/111(32%)patients. Organisms included MP 8(7.2%), CP 7(6.3%), RSV 10(9%), influenza A 4(3.6%), parainfluenza 2(1.8%), adenovirus 1(0.9%), enterovirus 1(0.9%), influenza B 1(0.9%) and CMV 1(0.9%). Two children had positive PPD's. MP and CP were not found by culture or PCR in healthy control children. Cure/improvement for azi was 43/44(98%) verses ery/aug 47/48(98%). To date MP and CP appear to be less common etiologies of CAP in Dallas than reported elsewhere in the United States.

Original languageEnglish (US)
Number of pages1
JournalClinical Infectious Diseases
Volume25
Issue number2
StatePublished - Dec 1 1997

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Evaluation of azithromycin in the treatment of pneumonia in ambulatory children: A randomized trial employing amoxicillin clavulanate or erythrotnycin estolate as comparative standard therapy'. Together they form a unique fingerprint.

  • Cite this

    Wubbel, L., Ahmed, A., Trujillo, M., Mccoig, C., Jafri, H., Olsen, K., Shelton, S., Muniz, L., Brito, F., Hoyt, J., Bakken, D., Carubelli, C., Abramo, T., & Mccracken, G. (1997). Evaluation of azithromycin in the treatment of pneumonia in ambulatory children: A randomized trial employing amoxicillin clavulanate or erythrotnycin estolate as comparative standard therapy. Clinical Infectious Diseases, 25(2).